KV

Kenvue Inc.

KVUEConsumer DefensiveNASDAQ

Household & Personal Products

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$15.12B
-2.1% YoY
Net Income
$1.47B
+42.7% YoY
EBITDA
$2.99B
+21.0% YoY
Free Cash Flow
$1.91B

Scan Results

Daily timeframe
DateIndicatorDetails
Sep 3 MACD Negative CrossoverHistogram -0.0303, negative momentum
Sep 2 MACD Negative CrossoverHistogram -0.0423, negative momentum
About Kenvue Inc.

Headquartered within the consumer defensive sector, Kenvue Inc. focuses on Household & Personal Products services and products. Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The $35.32B market capitalization puts KVUE squarely in large-cap range for its industry. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health.

Where KVUE stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, KVUE finished 6.69% above its 150-day moving average ($17.93) and 8.88% above its 200-day moving average ($17.57). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is KVUE overbought or oversold?

At the September 3, 2026 close, KVUE's RSI(14) was 48.6, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$35.32B
P/E (TTM)21.64
Fwd P/E14.81
EPS$0.85
Beta0.43
52W Change+1.5%
Dividend Yield4.48%
ROE15.6%
Analysis

The company holds $1.11B in cash, though total debt stands at $8.61B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $1.91B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 15.6% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.0% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $14.95B (2022) to $15.12B (2025).

With a beta below 0.7, Kenvue Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Kenvue Inc. and its sector.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms